[PMID: 39310241] PubMed record related to this compound for laboratory literature review
GLP-1 AND GIP Given the extensive clinical experience with GLP-1 RAs and the established safety profile in cardiovascular disease settings, peptide multi-agonists have been developed to target multihormonal peptide-secreting enteroendocrine cells.8 Due to their glucose-lowering functions, the combination of GLP-1 and GIP hormones is one of the most attractive strategies for treating T2DM.8, 9 GLP-1 was first identified as a cleavage product of preproglucagon generated by L cells in the small intestine and functions to increase postprandial insulin production and lower blood glucose.10, 11, 12, 13 Since its discovery, efforts have focused on extending GLP-1 agonist activity through structural changes.14 Liraglutide and semaglutide, two long-acting GLP-1 RAs, have been authorized for the treatment of T2DM and obesity
It is the ultimate detox and antidote to toxins
Anthem, a BCBS affiliate that operates in only 14 states, may cover Wegovy, but coverage is not guaranteed and varies significantly by plan and region
Alternatives to GLP-1 therapy for postpartum weight loss while breastfeeding For mothers who decide that GLP-1 therapy is not right during breastfeeding, or whose physicians recommend waiting until weaning, effective alternatives exist
A study on mice found that GLP-1s like Ozempic may have an anti-inflammatory effect on atherosclerosis